Effectiveness of Chemical Castration Sanctions and the Principle of Non-Discrimination: A Human Rights, Islamic Law, and SDGs Perspective
DOI:
https://doi.org/10.23917/profetika.v26i03.13627Keywords:
child sexual crimes, digital legal sanctions, online child protection, islamic law, sdgsAbstract
Objective: This study aims to analyze the application of chemical castration sanctions and the principle of non-discrimination from the perspective of criminal law and human rights in Indonesia, as well as to review these policies from the perspective of Islamic law (maqasid al-shariah) and the Sustainable Development Goals (SDGs). Theoretical framework: The theoretical framework of this research uses the concept of the rule of law, the principles of criminal law and human rights, the concept of maqasid al-shariah in Islamic law, and the perspective of SDGs related to justice, health, and the reduction of inequality. Literature review: A literature review analyzes various laws and regulations, court decisions, and academic studies related to the application of chemical castration sanctions as a legal phenomenon. Methods: The research uses normative juridical methods with a literature study approach through the analysis of laws and regulations, court decisions, legal journals, and law enforcement reports. Results: The results of the study show that the effectiveness of chemical castration sanctions is still in doubt and has the potential to contradict the principle of non-discrimination in the 1945 Constitution, ICCPR, and other international human rights instruments. Implications: Chemical castration policies create a dilemma between the protection of communities from sexual crimes and the protection of the human rights of perpetrators, as well as the debate from an Islamic perspective of Islam and the SDGs related to health, justice, and welfare. Novelty: The novelty of this research lies in the integrative analysis of chemical castration sanctions from the perspective of criminal law, human rights, Islamic law (maqasid al-shariah), and SDGs.
References
[1] A. Marddent, “Religious discourse and gender security in Southern Thailand,” Austrian J. South-East Asian Stud., vol. 12, no. 2, pp. 225–247, 2019, https://doi.org/10.14764/10.ASEAS-0023.
[2] A. K. Syafa’at, “Potensi Zakat, Infaq, Shodaqoh Pada Badan Amil Zakat Nasional (BAZNAS) Di Kabupaten Banyuwangi Abdul,” J. Chem. Inf. Model., vol. 53, no. 9, pp. 1689–1699, 2013, https://doi.org/10.1017/CBO9781107415324.004.
[3] N. Nasrullah, “Implementing Chemical Castration Punishment: A Perspective on Criminal Law and Human Rights,” SIGn J. Huk., vol. 4, no. 2, pp. 402–413, 2023, https://doi.org/10.37276/sjh.v4i2.282.
[4] Sujasmin Sujasmin, “Penerapan Sanksi Kebiri Kimia Bagi Pelaku Tindak Pidana Kekerasan Seksual Anak Dalam Perspektif Hak Asasi Manusia,” J. Usm Law Rev., vol. 8, no. 1, pp. 544–558, 2025, https://doi.org/10.26623/julr.v8i1.11774.
[5] M. Arifin, “Tinjauan Hukum Terhadap Hukuman Kebiri Menurut Undang-Undang Nomor 17 Tahun 2016 Tentang Perubahan Kedua Atas Undang – Undang Nomor 23 Tahun 2002 Tentang Perlindungan Anak,” Nusantara Journal of Islamic Studies, vol. 1, no. 2. pp. 82–87, 2020. https://doi.org/10.54471/njis.2020.1.2.82-87.
[6] I. M. Ellman and T. Ellman, “‘Frightening and High’: The Frightening Sloppiness of the High Court’s Sex Crime Statistics,” SSRN Electron. J., vol. 14, no. 2, 2015, https://doi.org/10.2139/ssrn.2616429.
[7] W. L. Marshall and C. Hollin, “Historical developments in sex offender treatment,” J. Sex. Aggress., vol. 21, no. 2, pp. 125–135, 2015, https://doi.org/10.1080/13552600.2014.980339.
[8] A. Syarbaini, “Konsep Ta’Zir Menurut Perspektif Hukum Pidana Islam,” J. Tahqiqa J. Ilm. Pemikir. Huk. Islam, vol. 17, no. 2, pp. 37–48, 2023, https://doi.org/10.61393/tahqiqa.v17i2.167.
[9] L. Arake, “Hukuman Kebiri Kimia Bagi Pelaku Kekerasan Seksual Terhadap Anak Perspektif Fiqh Siyasah,” Al-Adalah: Jurnal Hukum dan Politik Islam, vol. 5, no. 1. pp. 16–41, 2020. https://doi.org/10.35673/ajmpi.v5i1.676.
[10] R. Saputra, M. Zaid, P. Suwadi, J. Barkhuizen, and T. Tiolince, “Reconstruction of Chemical Castration Sanctions Implementation Based on the Medical Ethics Code (Comparison with Russia and South Korea),” Lex Sci. Law Rev., vol. 7, no. 1, pp. 61–118, 2023, https://doi.org/10.15294/lesrev.v7i1.64143.
[11] M. Efiyanti and G. Widjaja, “The implementation of chemical castration sanctions against convicts of child sexual crimes in Indonesia by doctors,” J. Leg. Ethical Regul. Issues, vol. 24, no. Special Issue 1, pp. 1–16, 2021, https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112837993&partnerID=40&md5=ce2db0c1f54ceaa68ece532bdfb619c5
[12] A. A. Baniahmad, G. Atri Roozbahani, M. Jung, and A. Baniahmad, “The bioactivity of atraric acid as an inducer of cellular senescence in prostate cancer cells is retained by lipophilic derivatives,” Naunyn. Schmiedebergs. Arch. Pharmacol., vol. 398, no. 9, pp. 11803–11819, 2025, https://doi.org/10.1007/s00210-025-03989-0.
[13] A. J. Macke et al., “Targeting the ATF6-Mediated ER Stress Response and Autophagy Blocks Integrin-Driven Prostate Cancer Progression,” Mol. Cancer Res., vol. 21, no. 9, pp. 958–974, 2023, https://doi.org/10.1158/1541-7786.MCR-23-0108.
[14] B. Zhang et al., “Discovery of BWA-522, a First-in-Class and Orally Bioavailable PROTAC Degrader of the Androgen Receptor Targeting N-Terminal Domain for the Treatment of Prostate Cancer,” J. Med. Chem., vol. 66, no. 16, pp. 11158–11186, 2023, https://doi.org/10.1021/acs.jmedchem.3c00585.
[15] T. Watabe et al., “Targeted α-therapy using astatine (211At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound,” Eur. J. Nucl. Med. Mol. Imaging, vol. 50, no. 3, pp. 849–858, 2023, https://doi.org/10.1007/s00259-022-06016-z.
[16] H. Gao et al., “Palmitic acid-modified GnRH-Th epitope peptide immunocastration vaccine (W/O/W adjuvant) can effectively ensure the castration and reduce the smell in boars,” Front. Vet. Sci., vol. 10, 2023, https://doi.org/10.3389/fvets.2023.1174770.
[17] R. L. Gonciarz et al., “Elevated labile iron in castration–resistant prostate cancer is targetable with ferrous iron–activatable antiandrogen therapy,” Eur. J. Med. Chem., vol. 249, 2023, https://doi.org/10.1016/j.ejmech.2023.115110.
[18] J. Monga, F. Valeriote, C. Hwang, S. Gadgeel, and J. Ghosh, “Daclatasvir, an Antiviral Drug, Downregulates Tribbles 2 Pseudokinase and Resensitizes Enzalutamide-Resistant Prostate Cancer Cells,” Mol. Cancer Ther., vol. 22, no. 3, pp. 381–392, 2023, https://doi.org/10.1158/1535-7163.MCT-21-1002.
[19] S. Zhao et al., “1-Benzyloxy-5-phenyltetrazole derivatives highly active against androgen receptor-dependent prostate cancer cells,” Eur. J. Med. Chem., vol. 246, 2023, https://doi.org/10.1016/j.ejmech.2022.114982.
[20] N. Mesbahi et al., “Second generation PSMA-targeted turn-on probe for imaging cargo release in prostate cancer cells,” Bioorganic Med. Chem. Lett., vol. 133, 2026, https://doi.org/10.1016/j.bmcl.2025.130530.
[21] G. A. Rather et al., “Facile synthesis of elastin nanogels encapsulated decursin for castrated resistance prostate cancer therapy,” Sci. Rep., vol. 14, no. 1, 2024, https://doi.org/10.1038/s41598-024-65999-x.
[22] R. Qiu, K. Bu, H. An, and N. Tao, “A retrospective study: analysis of the relationship between lactate dehydrogenase and castration-resistant prostate cancer based on restricted cubic spline model,” PeerJ, vol. 11, 2023, https://doi.org/10.7717/peerj.16158.
[23] S. Wang et al., “Structure-guided design of a selective inhibitor of the methyltransferase KMT9 with cellular activity,” Nat. Commun., vol. 15, no. 1, 2024, https://doi.org/10.1038/s41467-023-44243-6.
[24] A. Carrot et al., “Prognostic Value of the Modeled Prostate-Specific Antigen KELIM Confirmation in Metastatic Castration-Resistant Prostate Cancer Treated With Taxanes in FIRSTANA,” JCO Clin. Cancer Informatics, vol. 8, no. 8, 2024, https://doi.org/10.1200/cci.23.00208.
[25] G. Fazarinc et al., “Male Reproductive Organ Weight: Criteria for Detection of Androstenone-Positive Carcasses in Immunocastrated and Entire Male Pigs,” Animals, vol. 13, no. 12, 2023, https://doi.org/10.3390/ani13122042.
[26] S. Zeng et al., “Design and characterization of a novel prostate-specific membrane antigen-targeted radioligand modified with a fatty acid albumin binder for optimized circulation half-life,” EJNMMI Radiopharm. Chem., vol. 10, no. 1, 2025, https://doi.org/10.1186/s41181-025-00385-0.
[27] A. M. Shah et al., “Discovery of the Enrichment Pathways and Biomarkers using Metabolomics Techniques in Unilateral and Bilateral Castration in Yellow Cattle,” Pak. Vet. J., vol. 44, no. 2, pp. 252–259, 2024, https://doi.org/10.29261/pakvetj/2024.166.
[28] C. D. Cruz-Hernández et al., “A Cyanobacteria-Derived RNA Aptamer Resensitizes Prostate Cancer to Hormone Therapy,” Cancer Res., vol. 85, no. 14, pp. 2714–2725, 2025, https://doi.org/10.1158/0008-5472.CAN-24-4039.
[29] T. Nguyen et al., “Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancer,” Nat. Commun., vol. 14, no. 1, 2023, https://doi.org/10.1038/s41467-023-38887-7.
[30] Q. Cui, C. Huang, X. Zheng, Z. Dong, J. Y. Liu, and J. T. Zhang, “Design, synthesis, and evaluation of quinoxaline-based survivin inhibitors for castration-resistant prostate cancer,” Bioorg. Chem., vol. 163, 2025, https://doi.org/10.1016/j.bioorg.2025.108714.
[31] S. Basu et al., “Rational optimization of a transcription factor activation domain inhibitor,” Nat. Struct. Mol. Biol., vol. 30, no. 12, pp. 1958–1969, 2023, https://doi.org/10.1038/s41594-023-01159-5.
[32] M. Comin et al., “Heavy Pigs Reared for Italian Dry-Cured Products: Does Immunocastration Influence the Fatty Acid Profile of Loins and Backfat?” Animals, vol. 14, no. 9, 2024, https://doi.org/10.3390/ani14091284.
[33] T. Matsuoka et al., “Newly developed preclinical models reveal broad-spectrum CDK inhibitors as potent drugs for CRPC exhibiting primary resistance to enzalutamide,” Cancer Sci., vol. 115, no. 1, pp. 283–297, 2024, https://doi.org/10.1111/cas.15984.
[34] S. A. Ayodeji, Y. Balytskyi, D. Unaegbu, A. Ingman, C. V. Kelly, and S. Roberts, “High-Affinity Probes for Androgen Receptor Imaging: From Cells and In Silico Modeling to Whole-Body Fluorescent Applications,” J. Med. Chem., vol. 68, no. 15, pp. 15812–15827, 2025, https://doi.org/10.1021/acs.jmedchem.5c00836.
[35] B. Cevatemre et al., “Exploiting epigenetic targets to overcome taxane resistance in prostate cancer,” Cell Death Dis., vol. 15, no. 2, 2024, https://doi.org/10.1038/s41419-024-06422-1.
[36] M. Sharifi et al., “Steroid Sulfatase Regulates Metabolic Reprogramming in Advanced Prostate Cancer,” Cancers (Basel), vol. 17, no. 12, 2025, https://doi.org/10.3390/cancers17121959.
[37] R. S. Thankan, E. Thomas, P. Purushottamachar, D. J. Weber, and V. C. O. Njar, “Salinization Dramatically Enhances the Anti-Prostate Cancer Efficacies of AR/AR-V7 and Mnk1/2 Molecular Glue Degraders, Galeterone and VNPP433-3β, Which Outperform Docetaxel and Enzalutamide in CRPC CWR22Rv1 Xenograft Mouse Model,” Bioorg. Chem., vol. 139, 2023, https://doi.org/10.1016/j.bioorg.2023.106700.
[38] A. C. Logan, P. Mishra, and S. L. Prescott, “The Legalome: Microbiology, Omics and Criminal Justice,” Microb. Biotechnol., vol. 18, no. 3, 2025, https://doi.org/10.1111/1751-7915.70129.
[39] K. Solberg, “Pakistan moves to tackle acid violence,” The Lancet, vol. 376, no. 9748, pp. 1209–1210, 2010, https://doi.org/10.1016/S0140-6736(10)61863-6.
[40] Y. E. Fitria, D. Vianto, A. Mashdurohatun, S. E. Wahyuningsih, J. Hafidz, and D. Setiyawan, “Chemical castration in the criminal law system: A study of effectiveness and toxicological impact,” Edelweiss Appl. Sci. Technol., vol. 8, no. 6, pp. 8907–8914, 2024, https://doi.org/10.55214/25768484.v8i6.3887.
[41] L. Gable and J. W. Buehler, “Criticized, fired, sued, or prosecuted: Hindsight and public health accountability,” Public Health Rep., vol. 132, no. 6, pp. 676–678, 2017, https://doi.org/10.1177/0033354917730820.
[42] A. R. Cashmore, “The Lucretian swerve: The biological basis of human behavior and the criminal justice system,” Proc. Natl. Acad. Sci. U. S. A., vol. 107, no. 10, pp. 4499–4504, 2010, https://doi.org/10.1073/pnas.0915161107.
[43] F. Asicioglu, E. E. Kucukibrahimoglu, and U. Ilingi, “Psychotropic drugs evaluated in the context of narcotic drugs according to the new Turkish criminal law,” Klin. Psikofarmakol. Bul., vol. 20, no. 4, pp. 314–320, 2010, https://doi.org/10.1080/10177833.2010.11790678.
[44] J. M. B. Guillén, “Community treatment orders: Bioethical basis,” Eur. J. Psychiatry, vol. 25, no. 3, pp. 134–143, 2011, https://doi.org/10.4321/S0213-61632011000300003.
[45] S. H. Lee, J. H. Kwon, Y. W. Won, and J. H. Kang, “Palliative Sedation in End-of-Life Patients in Eastern Asia: A Narrative Review,” Cancer Res. Treat., vol. 54, no. 3, pp. 644–650, 2022, https://doi.org/10.4143/CRT.2022.187.
[46] M. P. Chavula, J. M. Zulu, I. Goicolea, and A. K. Hurtig, “Unlocking policy synergies, challenges and contradictions influencing implementation of the Comprehensive Sexuality Education Framework in Zambia: a policy analysis,” Heal. Res. Policy Syst., vol. 21, no. 1, 2023, https://doi.org/10.1186/s12961-023-01037-y.
Downloads
Submitted
Accepted
Published
Issue
Section
License
Copyright (c) 2026 Adystia Sunggara
This work is licensed under a Creative Commons Attribution 4.0 International License.
